| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 45.88B | 44.73B | 39.25B | 33.16B | 28.10B | 23.60B |
| Gross Profit | 17.17B | 16.52B | 14.22B | 11.74B | 9.56B | 8.47B |
| EBITDA | 12.26B | 12.89B | 11.35B | 8.92B | 7.67B | 5.83B |
| Net Income | 8.92B | 9.07B | 7.50B | 5.63B | 4.76B | 3.15B |
Balance Sheet | ||||||
| Total Assets | 73.34B | 70.78B | 63.25B | 56.63B | 50.77B | 44.78B |
| Cash, Cash Equivalents and Short-Term Investments | 21.93B | 22.22B | 18.79B | 18.52B | 17.03B | 14.33B |
| Total Debt | 16.60B | 21.70B | 12.15B | 14.33B | 11.71B | 10.40B |
| Total Liabilities | 34.20B | 32.24B | 27.57B | 25.22B | 21.78B | 18.49B |
| Stockholders Equity | 39.14B | 37.58B | 35.69B | 31.43B | 29.00B | 26.31B |
Cash Flow | ||||||
| Free Cash Flow | 4.42B | 5.70B | 3.08B | 3.15B | 2.76B | 3.35B |
| Operating Cash Flow | 10.23B | 11.41B | 8.56B | 7.62B | 5.89B | 5.68B |
| Investing Cash Flow | -7.21B | -5.97B | 55.73M | -4.45B | -7.66B | -1.86B |
| Financing Cash Flow | -2.45B | -4.70B | -3.36B | -2.28B | -1.24B | 1.95B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$173.03B | 19.54 | 24.34% | 4.35% | 16.74% | 24.19% | |
73 Outperform | HK$42.03B | 12.46 | 12.26% | 1.39% | 11.26% | 15.82% | |
64 Neutral | HK$19.41B | 9.04 | 9.88% | 2.03% | -3.02% | 11.38% | |
62 Neutral | HK$12.72B | 20.23 | 4.89% | 1.02% | 7.11% | 65.26% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | HK$15.61B | 20.10 | 8.92% | 1.37% | 32.03% | 21.02% | |
59 Neutral | HK$1.95B | 34.32 | 2.32% | 3.20% | -9.47% | -72.44% |